Related Experiment Video

Updated: Apr 26, 2026

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
07:20

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Published on: February 10, 2023

2.7K

Recent advancements in the cardiovascular drug carriers

Baljeet Singh1, Tarun Garg1, Amit K Goyal1

  • 1a Department of Pharmaceutics , ISF College of Pharmacy , Moga , Punjab , India.

Artificial Cells, Nanomedicine, and Biotechnology
|July 22, 2014
PubMed

Insights

This review explores nanocarriers for advanced heart failure treatments, aiming to overcome limitations of current therapies like poor stability and nonspecific effects for better cardiovascular disease management.

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Medicine
  • Nanotechnology

Background:

  • Cardiovascular disease, including heart failure, remains a major global health challenge.
  • Current pharmacological and clinical treatments have limitations in efficacy and safety.
  • Novel therapeutic strategies are crucial for managing heart failure morbidity and mortality.

Purpose of the Study:

  • To review advancements in nanocarrier technology for cardiovascular disease treatment.
  • To address challenges associated with traditional and emerging heart failure therapeutics.
  • To highlight how nanocarriers can improve therapeutic stability and specificity.

Main Methods:

  • Literature review of recent research on nanocarriers in heart failure therapy.
  • Analysis of therapeutic strategies including cell transplantation, gene therapy, and small molecules.
  • Evaluation of nanocarrier-based approaches to overcome limitations of current treatments.

Main Results:

  • Nanocarriers offer potential for targeted drug delivery and improved therapeutic stability.
  • They can mitigate nonspecific effects common with conventional heart failure treatments.
  • Advancements in nanocarrier design show promise for enhanced efficacy in cardiovascular medicine.

Conclusions:

  • Nanocarrier technology represents a significant advancement in treating heart failure.
  • Addressing issues of stability and specificity is key to improving cardiovascular disease outcomes.
  • Further research into nanocarriers can lead to more effective and safer heart failure therapies.

Keywords:
Nanoparticlecardiovascular diseasegene therapynanotechnological approaches

More Related Videos

Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging10:50

Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging

Published on: June 29, 2013

11.6K
3D Whole-heart Myocardial Tissue Analysis06:53

3D Whole-heart Myocardial Tissue Analysis

Published on: April 12, 2017

8.4K

Related Concept Videos

Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
297
Modified-Release Drug Delivery Systems: Overview01:19

Modified-Release Drug Delivery Systems: Overview

Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
231
Oral Drug Delivery Systems: Introduction01:23

Oral Drug Delivery Systems: Introduction

Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
271
Drug Delivery Systems: Different Types01:27

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
391
Drug Delivery: Overview01:16

Drug Delivery: Overview

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.2K
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
204